Arcosa stock will likely trade near the $150 deal price, with the spread reflecting time value and regulatory/approval risk. Monitor for stockholder vote timing and antitrust review progress. The absence of a financing condition reduces deal risk. Consider merger arbitrage positioning if the spread is attractive relative to the Q1 2027 expected close.
How the stock moved after the report
⚠ Clustered BULLISH VIEWSTOCK ABOVE ENTRY AT T+60- T+0 · Jun 22 $144.90entry
- T+1 · 5mo ago +0.01%α +1.47% · $144.92
- T+5 · 5mo ago −0.28%α +1.79% · $144.50
- T+20 · 4mo ago +0.08%α +0.22% · $145.01
- T+60 · 2mo ago +0.17%α −1.13% · $145.14
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Arcosa (ACA) has entered into a definitive merger agreement to be acquired by CRH Americas for $150 per share in cash, representing a total enterprise value of approximately $8.5 billion. The all-cash transaction offers a 25% premium to Arcosa's 60-day VWAP and is expected to close in Q1 2027, subject to stockholder and regulatory approvals.
Key Financial Metrics
Key Facts
- $150 per share all-cash consideration, implying a total enterprise value of approximately $8.5 billion
- 25% premium to Arcosa's 60-day VWAP as of June 18, 2026
- Acquisition multiple of 11.5x 2026E Adjusted EBITDA including $175 million in estimated annual run-rate cost synergies by year three
- Arcosa's Board unanimously approved the transaction and recommends stockholders vote in favor
- Transaction expected to close in Q1 2027; no financing condition for CRH
- Termination fees: $260.4M payable by Arcosa under certain circumstances (e.g., superior proposal), $372.0M payable by CRH if antitrust-related conditions fail
Financial Impact
Arcosa stockholders receive $150 per share in cash, a 25% premium to the unaffected price. The $8.5B enterprise value represents a significant monetization event.
Risk Factors
- Failure to obtain stockholder approval (majority of outstanding shares required)
- Regulatory delays or prohibition under HSR Act or other antitrust laws
- Material adverse change or breach of representations/warranties allowing termination
- Competing superior proposal triggering termination fee
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 6 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001739445-26-000112 |
| Exhibit: exh991-crhtoacquirearcos.htm | 0001739445-26-000112 |
| Document: aca-20260621.htm | 0001739445-26-000112 |
| Document: 0001739445-26-000112-index-headers.html | 0001739445-26-000112 |
| Document: 0001739445-26-000112-index.html | 0001739445-26-000112 |
| Document: 0001739445-26-000112.txt | 0001739445-26-000112 |
Track record
16 reports on ACA
3 of 4 bullish or bearish reports moved the stock their way by T+60. Best: +17.74% at T+60 after the Jun 5, 2026 report. 4 of 4 went positive at some point.
Filters
- Nov 4, 202612d ago Institutional Cluster Bearish 4/10 No price data
- Nov 2, 202614d ago 15-12G Neutral 3/10 No price data
- Oct 23, 202624d ago 25-NSE Mixed 8/10 Entry $149.50 settles Jan 21
- Oct 23, 202624d ago 25-NSE Bullish 7/10 Entry $149.50 settles Jan 21
- Oct 23, 202624d ago 8-K / 25-NSE Mixed 8/10 Entry $149.50 settles Jan 21
- Aug 25, 202611w ago DEFA14A Neutral 3/10 Entry $145.25 settles Nov 18
- Aug 14, 202613w ago Institutional Cluster Mixed 5/10 Entry $145.01 due Nov 10
- Aug 5, 202614w ago DEFA14A Neutral 4/10 Entry $144.89 No price data
- Jun 22, 202621w ago DEFA14A Bullish 7/10 Entry $144.92 to $145.45 ▲ +0.37% −3.59% vs SPY
- Jun 22, 202621w ago DEFA14A Bullish 7/10 Entry $144.92 to $145.45 ▲ +0.37% −3.59% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers